fosaprepitant  - Drug Details
📊 Estimates fosaprepitant  Dialyzability By Different_Modalities

fosaprepitant 

Complete Drug Information

Drug Name
fosaprepitant 
Trade Names
Emend, Ivemend
Pregnancy Category
AU: B2
Bioavailability
n/a
Routes of Administration
Intravenous
Protein Binding
>95% (aprepitant)%
Metabolism
To aprepitant
Elimination
9 to 13 hours (aprepitant)
Formula
C23H22F7N4O6P
Molar Mass
614.414
Volume of Distribution
82 L/kg

🤰 Pregnancy Category Information

Category: AU: B2

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage.